Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome
Marie‐Andrée Forget, Cara Haymaker, Kenneth R. Hess, et al.
Clinical Cancer Research (2018) Vol. 24, Iss. 18, pp. 4416-4428
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Review of precision cancer medicine: Evolution of the treatment paradigm
Apostolia M. Tsimberidou, Elena Fountzilas, Mina Nikanjam, et al.
Cancer Treatment Reviews (2020) Vol. 86, pp. 102019-102019
Open Access | Times Cited: 514
T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
Smita S. Chandran, Christopher A. Klebanoff
Immunological Reviews (2019) Vol. 290, Iss. 1, pp. 127-147
Open Access | Times Cited: 255
Ovarian Cancer Immunotherapy and Personalized Medicine
Susan Morand, Monika Devanaboyina, Hannah Staats, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6532-6532
Open Access | Times Cited: 249
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
U. Dafni, Olivier Michielin, Silvia Martin Lluesma, et al.
Annals of Oncology (2019) Vol. 30, Iss. 12, pp. 1902-1913
Open Access | Times Cited: 202
Immune checkpoint inhibitors: The linchpins of modern immunotherapy
Breelyn A. Wilky
Immunological Reviews (2019) Vol. 290, Iss. 1, pp. 6-23
Closed Access | Times Cited: 177
Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
Yuka Igarashi, Tetsuro Sasada
Journal of Immunology Research (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 156
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up
Joost H. van den Berg, Bianca Heemskerk, Nienke van Rooij, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000848-e000848
Open Access | Times Cited: 151
T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
Apostolia M. Tsimberidou, Karlyle Van Morris, Henry Hiep Vo, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 117
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma
Rodabe N. Amaria, Anne Knisely, David Vining, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 2, pp. e006822-e006822
Open Access | Times Cited: 20
Art of TIL immunotherapy: SITC’s perspective on demystifying a complex treatment
Simon Turcotte, Marco Donia, Brian Gastman, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010207-e010207
Open Access | Times Cited: 2
Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully
Baisheng Lin, Likun Du, Hongmei Li, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110873-110873
Open Access | Times Cited: 135
Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
Zihai Li, Wenru Song, Mark P. Rubinstein, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 109
Immunotherapies and Combination Strategies for Immuno-Oncology
Cody Barbari, Tyler Fontaine, Priyanka Parajuli, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5009-5009
Open Access | Times Cited: 103
Personalized immunotherapy in cancer precision medicine
Kazuma Kiyotani, Yujiro Toyoshima, Yusuke Nakamura
Cancer Biology and Medicine (2021) Vol. 18, Iss. -
Open Access | Times Cited: 95
Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives
Roman P. Labbé, Sandrine Vessillier, Qasim A. Rafiq
Viruses (2021) Vol. 13, Iss. 8, pp. 1528-1528
Open Access | Times Cited: 86
Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma
Samantha J. Seitter, Richard M. Sherry, James Chih‐Hsin Yang, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 19, pp. 5289-5298
Open Access | Times Cited: 73
Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future
Allison Betof Warner, Pippa Corrie, Omid Hamid
Clinical Cancer Research (2022) Vol. 29, Iss. 10, pp. 1835-1854
Open Access | Times Cited: 51
Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer
Aislyn Schalck, Donastas Sakellariou-Thompson, Marie‐Andrée Forget, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2330-2349
Open Access | Times Cited: 50
The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma
Madison Ernst, Alessio Giubellino
Biomedicines (2022) Vol. 10, Iss. 4, pp. 822-822
Open Access | Times Cited: 46
Biomarkers for response to TIL therapy: a comprehensive review
Víctor Albarrán, P Martínez, Joachim Stoltenborg Granhøj, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008640-e008640
Open Access | Times Cited: 14
Efficacy of TIL Therapy in Advanced Cutaneous Melanoma in the Current Immuno-oncology Era: Updated Systematic Review and Meta-analysis
Silvia Martin Lluesma, Inge Marie Svane, Urania Dafni, et al.
Annals of Oncology (2024) Vol. 35, Iss. 10, pp. 860-872
Closed Access | Times Cited: 9
Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?
Liam Masterson, James Howard, Jazmina L. G. Cruz, et al.
International Journal of Cancer (2020) Vol. 146, Iss. 8, pp. 2305-2314
Open Access | Times Cited: 60
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
Anders H. Kverneland, Christopher A. Chamberlain, Troels Holz Borch, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e003499-e003499
Open Access | Times Cited: 42
Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: Ready for Prime Time?
Alhadi Almangush, Stijn De Keukeleire, Sylvie Rottey, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1558-1558
Open Access | Times Cited: 31
Advances in adoptive T-cell therapy for metastatic melanoma
Aparimita Das, Aruni Ghose, Kevin Naicker, et al.
Current Research in Translational Medicine (2023) Vol. 71, Iss. 3, pp. 103404-103404
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top